Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. - Wikidata - wikimedia - TriplyDB

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

http://www.wikidata.org/entity/Q41974684

about

On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari Different modes of vancomycin and D-alanyl-D-alanine peptidase binding to cell wall peptide and a possible role for the vancomycin resistance protein Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?Lipid Flippases for Bacterial Peptidoglycan Biosynthesis ABC transporters of antimicrobial peptides in Firmicutes bacteria - phylogeny, function and regulation Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII Vancomycin dimer formation between analogues of bacterial peptidoglycan surfaces probed by force spectroscopy.Probing the specific interactions and structures of gas-phase vancomycin antibiotics with cell-wall precursor through IRMPD spectroscopy.Glycans in pathogenic bacteria--potential for targeted covalent therapeutics and imaging agents.Alterations in peptidoglycan precursors and vancomycin susceptibility in Tn917 insertion mutants of Enterococcus faecalis 221 Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.A mutant Escherichia coli that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface.Additional antibiotic inhibitors of peptidoglycan synthesis.Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.Heterogeneity of newly inserted and preexisting murein in the sacculus of Escherichia coli Amino acid derived macrocycles--an area driven by synthesis or application?Lipid II as a target for antibiotics.Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus On the evolution of functional secondary metabolites (natural products).Role of autolysins in the killing of bacteria by some bactericidal antibiotics Relative affinity of vancomycin and ristocetin for cell walls and uridine diphosphate-N-acetylmuramyl pentapeptide Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.Expanding role of lipid II as a target for lantibiotics.Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions.Detection of soluble peptidoglycan in urine after penicillin administration.Investigation into the functional impact of the vancomycin C-ring aryl chloride Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies.Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.Recent developments in enediyne chemistry.Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.Vancomycin: an update.Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.Bacitracin-induced proteins in Bacillus subtilis and Bacillus thuringiensis and their relationship with resistance.Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.Vancomycin resistance in Enterococcus gallinarum.

P2860

Q24564343-02E26C79-728C-4FFA-8C4F-7B855C1E4322 Q24670922-F15A7309-41C3-4CAE-A6F5-E5588661D925 Q24678550-934CD979-0071-4476-8AE4-894C1BB688F0 Q26770493-F7056C7E-2AE6-4BB2-8DAE-1DD85A431607 Q26851706-454B68C5-9899-4EEF-87C9-09BDC0D6E14C Q27676948-B00C6C71-E025-4720-9666-862660289042 Q33462122-33C6010A-CBBC-4039-B361-F72F0A3DDD0A Q33532186-A967BDBA-CC2B-40F4-911B-0727E191E9DD Q33545652-2277F95F-33FF-49F8-B924-89478593D325 Q33725733-C01A2ACE-DBC5-4CE5-94F8-020BD36C4311 Q33750659-E7AD5199-C02A-4623-AB05-872978BCDF90 Q34042099-D70977D0-3EBD-487D-9198-787EB5703AAD Q34262435-BBB32C79-2C58-4B69-9A6D-7D9589644FF0 Q34308628-DCF813C8-034B-44EC-AD91-479FC2C97E08 Q34975937-17C68036-17D4-4494-9AE6-366359A10F28 Q35652319-845837FE-D501-4BA6-93AA-F5EBF210C906 Q35683194-50C17591-AF61-407A-A832-6F21C3D18985 Q36370730-A780C31E-4E71-426A-8BEF-7681705660B5 Q36380943-4976AAFD-8531-4C00-AF8D-413AE85E1E65 Q36419233-0F155382-B578-4002-8AA6-6C6B9D3A3BEF Q36512904-13EF1D7C-44F8-4368-8111-26A27D46572E Q36769198-3EB8E2C9-4754-48F9-A270-8235921C874A Q36774337-F569FB75-9527-4C99-88FF-73BF358DBF11 Q36778037-A92E24EE-FD80-4083-8BC9-D3370A4AA81E Q36886883-3BF26698-5C55-479A-8A6E-840E02B04F78 Q36967247-E03CE388-480F-4E0F-9CB8-8A9676C9DD61 Q37033825-DD5232D2-1181-4BB3-82C4-915CB7DB0F55 Q37079888-6AD10125-C84F-423C-8F99-DBC7ADEA8E07 Q37134012-52E70F1C-EA69-441C-BBB3-3D54CC76A783 Q37378671-2EDDE7F4-EF84-48E6-B7F5-71CD5C609E4E Q37395641-49493A60-8B39-45B0-BC1A-B33FE870021A Q37994131-A5771639-59DB-476A-832F-D268D6C1306E Q38313962-C34BE862-22A2-4DB3-A0C9-C0334A11BAA9 Q38340509-E36AB47F-33A2-445B-8922-E31460BC7F44 Q39258608-599FB26B-477D-48FC-B7B4-94A40253D925 Q39746652-6476EF94-0838-4E1A-B2AE-94F275920F25 Q39815348-B8F33A02-1C83-46D6-82D5-053A94E0B5D6 Q39815891-8B346BCA-9026-4C42-B8EB-DD49CCCABC3F Q39849471-3AF95310-995F-47F8-8605-AAE9F8B2855E Q39879623-006E5E26-6FBD-4078-8A6F-8F2C5BB5A230

P2860

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

http://www.wikidata.org/entity/Q41974684

description

1969 nî lūn-bûn

@nan

1969年の論文

@ja

1969年論文

@yue

1969年論文

@zh-hant

1969年論文

@zh-hk

1969年論文

@zh-mo

1969年論文

@zh-tw

1969年论文

@wuu

1969年论文

@zh

1969年论文

@zh-cn

name

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

@en

type

label

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

@en

prefLabel

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

@en

P1433

Q41974684-EC5C13CB-4D2C-4BA8-9FB6-10D764A6C188

P1476

Q41974684-8A81EC4A-3724-4AFD-A65E-012515C3D665

P2093

Q41974684-AADBC047-3E27-4902-91BC-D2B93084681A

P2860

Q41974684-098DEEC7-D500-4DFC-B89A-E7DCC9A633D1

Q41974684-1187148C-69F9-4EA1-AEAA-855B1401FCFB

Q41974684-1DC94376-A4E7-44E5-BDEC-ED49ED040930

Q41974684-30527312-8085-4E60-934F-9A02A15BA41E

Q41974684-37F783B2-0487-4E7A-813F-D98382A09FC5

Q41974684-39BAC635-97B1-4EED-A918-ACA0C557F907

Q41974684-76082CCD-12E9-4FDB-8C7F-9626D79CF655

Q41974684-984A14BF-F6E2-42A7-8BAA-D731510D8769

Q41974684-DB308735-7951-445C-92B2-5364013EDCC0

Q41974684-F86CE4E5-5456-4BB5-A9ED-E013EA421586

P304

Q41974684-FCC6A8BA-4AFF-484A-86BB-2B28F3815F13

P31

Q41974684-2CCCDC64-C71B-477A-BD1C-0BE1E8A6C706

P356

Q41974684-D4D1A997-3D4C-40DE-8E20-C6C417F42886

P407

Q41974684-700D4597-EA44-4D91-9B26-9F94118E0AC7

P433

Q41974684-F6695D3E-C540-4970-AADA-C314772956CD

P478

Q41974684-7C276031-B034-47D9-8EF0-8E1433E4B903

P577

Q41974684-961990CC-219A-433E-A429-14AD421D0B0D

P5875

Q41974684-2D0D1D86-3D6E-4E89-8A8E-FD1F4A7C6690

P698

Q41974684-BF0C1D56-EE4A-4E68-BFD1-CCF9A92588B8

P932

Q41974684-6F06D95B-CB1F-4328-BFFA-00AAA0607E84

P356

P1433

Biochemical Journal

P1476

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

@en

P2093

Perkins HR

http://www.w3.org/2001/XMLSchema#string

P2860

Biosynthesis of the peptidoglycan of bacterial cell walls. XIV. Purification and properties of two D-alanine carboxypeptidases from Escherichia coli.

BAGSHAPED MACROMOLECULES--A NEW OUTLOOK ON BACTERIAL CELL WALLS.

Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine.

LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS

Glycopeptide transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions

Degradation, structure and some derivatives of cephalosporin N.

Filter-paper partition chromatography of sugars: 1. General description and application to the qualitative analysis of sugars in apple juice, egg white and foetal blood of sheep. with a note by R. G. Westall.

Protein-polyelectrolyte interactions. The concanavalin A precipitin reaction with polyelectrolytes and polysaccharide derivatives.

The cell wall of Bacillus licheniformis N.C.T.C. 6346. Isolation of low-molecular-weight fragments from the soluble mucopeptide.

Biosynthesis of the peptidoglycan of bacterial cell walls. 8. Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reaction in strains of Escherichia coli.

P304

195-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ1110195

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

1969-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17421897

http://www.w3.org/2001/XMLSchema#string

P698

5763787

http://www.w3.org/2001/XMLSchema#string

P932

1187807

http://www.w3.org/2001/XMLSchema#string